-
November 11, 2025
Xeureka Signs Contract with RealizeEdge Partners for the Discovery of Candidate Compounds for Targeted Protein DegradersREAD MORE
-
November 07, 2025
Our General Manager of Science & Technology, Ryushi Seo, will present at the Pioneering Drug Discovery Technology/Art for the Future session of the 42nd Medicinal Chemistry SymposiumREAD MORE
-
October 17, 2025
Sponsored Session at the CBI Annual Meeting 2025: GPU × AI-Powered Drug Discovery R&D — Sharing Knowledge and Growing the Tokyo-1 CommunityREAD MORE
-
April 23, 2025
Xeureka begins AI drug discovery research support on constrained peptides with FunPepREAD MORE
-
December 23, 2024
Xeureka Held the Second Executive Board Meeting of Tokyo-1READ MORE
-
November 21, 2024
Sponsored Session at the CBI Annual Meeting 2024: “Accelerating Drug Discovery Innovation in the Tokyo-1 Community: The Future of Drug Discovery Unlocked by Cutting-Edge GPU Computing”READ MORE
-
November 18, 2024
Our CTO, Hiroki Makiguchi, Takes the Stage at BioJapan-Hosted Seminar: “The AI Revolution in Drug Discovery”READ MORE
-
August 21, 2024
Notice of Address ChangeREAD MORE
-
August 07, 2024
Xeureka begins AI drug discovery support for FunPep research on antibody-inducing peptidesREAD MORE
